Annals of Surgery · 2000 · 238 citations · 23 references
MedicineOncologyPathologyBreast OncologyHistopathologySurgical PathologyBreast PathologyBreast SurgeryLymph Node PathologySentinel Lymph Node BiopsySentinel Lymph Node ImagingSentinel Lymph Node MappingAxillary Node ImagingAxillary Sentinel Lymph Node BiopsyBreast Cancer Sentinel Node MappingBreast Cancer Sentinel Node TechniqueMammary Lymphatic SystemSentinel Lymph Node AnatomySentinel Lymph Node IdentificationSentinel Node-positive Breast Cancer
OBJECTIVE: To simplify and improve the technique of axillary sentinel node biopsy, based on a concept of functional lymphatic anatomy of the breast. SUMMARY BACKGROUND DATA: Because of their common origin, the mammary gland and its skin envelope share the same lymph drainage pathways. The breast is essentially a single unit and has a specialized lymphatic system with preferential drainage, through select channels, to designated (sentinel) lymph nodes in the lower axilla. METHODS: These hypotheses were studied by comparing axillary lymph node targeting after intraparenchymal peritumoral radiocolloid (detected by a gamma probe) with the visible staining after an intradermal blue dye injection, either over the primary tumor site (90 procedures) or in the periareolar area (130 procedures). The radioactive content, blue coloring, and histopathology of the individual lymph nodes harvested during each procedure were analyzed. RESULTS: Radiolabeled axillary nodes were identified in 210 procedures, and these were colored blue in 200 cases (94%). The targeting concordance between peritumoral radiocolloid and intradermal blue dye was unrelated to the breast tumor location or the site of dye injection. Radioactive sentinel nodes were not stained blue in 10 procedures (5%), but this mismatching could be explained by technical problems in all cases. In two cases (1%), the (pathologic) sentinel node was blue but had no detectable radiocolloid uptake. CONCLUSIONS: The lessons learned from this study provide a functional concept of the breast lymphatic system and its role in metastasis. Anatomical and clinical investigations from the past strongly support these views, as do recent sentinel node studies. Periareolar blue dye injection appears ideally suited to identify the principal (axillary) metastasis route in early breast cancer. Awareness of the targeting mechanism and inherent technical restrictions remain crucial to the ultimate success of sentinel node biopsy and may prevent disaster.
23
The Sentinel Node in Breast Cancer — A Multicenter Validation Study
David N. Krag, Donald L. Weaver, Takamaru Ashikaga et al. · New England Journal of Medicine · 1998 · 2K citations · Full text
Sentinel lymphadenectomy in breast cancer.
A. E. Giuliano, Ronald C. Jones, Murray F. Brennan et al. · Journal of Clinical Oncology · 1997 · 1.1K citations
Guidelines for Sentinel Node Biopsy and Lymphatic Mapping of Patients With Breast Cancer
Charles E. Cox, Solange Pendas, John M. Cox et al. · Annals of Surgery · 1998 · 603 citations
Observations on a “sentinel node” in cancer of the parotid
Ernest A. Gould, T Winship, Philip H. Philbin et al. · Cancer · 1960 · 448 citations · Full text
Medicine, Neck Surgery, Oncology +12